54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES

Breast cancer is the second leading cause of brain metastases in women; patients with breast cancer brain metastasis (BCBM) survive an average of 6–18 months following diagnosis. Cancer stem cells are thought to be one of the driving forces behind distant metastasis, treatment resistance, and late-s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Doheny, Daniel, Sirkisoon, Sherona, Rimkus, Tadas, Zhu, Dongqin, Aguayo, Noah, Anguelov, Marlyn, Manore, Sara, Regua, Angelina, Thomas, Alexandra, Henson-Masters, Adrianna, Strowd, Roy, Lo, Hui-Wen
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Supplement Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401397/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa073.042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars